U.S. Veterinary Biomarkers Market Size & Outlook
Related Markets
U.S. veterinary biomarkers market highlights
- The U.S. veterinary biomarkers market generated a revenue of USD 350.1 million in 2024 and is expected to reach USD 717.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.8% from 2025 to 2030.
- In terms of segment, companion animals was the largest revenue generating animal type in 2024.
- Companion Animals is the most lucrative animal type segment registering the fastest growth during the forecast period.
Veterinary biomarkers market data book summary
| Market revenue in 2024 | USD 350.1 million |
| Market revenue in 2030 | USD 717.4 million |
| Growth rate | 12.8% (CAGR from 2025 to 2030) |
| Largest segment | Companion animals |
| Fastest growing segment | Companion Animals |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Companion Animals, Production Animals |
| Key market players worldwide | Zoetis, Virbac SA, Merck & Co Inc, IDEXX Laboratories Inc, Avacta Group PLC, Life Diagnostics, Mercodia, Antech Diagnostics |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.6% of the global veterinary biomarkers market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. veterinary biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 46.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Biomarkers Market Scope
Veterinary Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mercodia | View profile | 51-100 | Uppsala, Uppsala Lan, Sweden, Europe | http://www.mercodia.com |
| Life Diagnostics | View profile | 1-10 | West Chester, Pennsylvania, United States, North America | http://lifediagnostics.com |
| Avacta Group PLC | View profile | 113 | Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, United Kingdom, LS23 7FA | https://www.avacta.com |
| Zoetis | View profile | 10001+ | Parsippany, New Jersey, United States, North America | https://www.zoetis.com |
| Antech Diagnostics | View profile | 1001-5000 | Irvine, California, United States, North America | https://www.antechdiagnostics.com |
| IDEXX Laboratories Inc | View profile | 11000 | One IDEXX Drive, Westbrook, ME, United States, 04092 | https://www.idexx.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
U.S. veterinary biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary biomarkers market will help companies and investors design strategic landscapes.
Companion animals was the largest segment with a revenue share of 69.15% in 2024. Horizon Databook has segmented the U.S. veterinary biomarkers market based on companion animals, production animals covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary biomarkers market in the U.S. is experiencing significant growth, driven by the increasing prevalence of chronic conditions such as cancer and cardiovascular diseases in animals. This trend is fueling the demand for biomarker-based diagnostic assays that enable early disease detection.
For instance, in June 2024, Oxford BioDynamics (OBD) developed EpiSwitch SCB, a highly accurate, non-invasive blood test for detecting six common canine cancers, including lymphoma, sarcoma, and melanoma.
Validated through 3D whole-genome profiling, the test offers >89% accuracy for specific cancers, addressing a critical gap in veterinary oncology by providing precise cancer-type identification. EpiSwitch SCB is set for real-world validation and commercialization via partnerships, positioning OBD in the growing U.S. veterinary biomarkers market, where demand for advanced, non-invasive diagnostic solutions is increasing.
Reasons to subscribe to U.S. veterinary biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. veterinary biomarkers market databook
-
Our clientele includes a mix of veterinary biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
US Animal Type - Veterinary Biomarkers Market size, 2024 - 2030 (US$M)
U.S. Veterinary Biomarkers Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
